Growth Metrics

Exact Sciences (EXAS) Return on Equity (2016 - 2025)

Exact Sciences (EXAS) has disclosed Return on Equity for 15 consecutive years, with 0.08% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity rose 28.0% to 0.08% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.08%, a 28.0% increase, with the full-year FY2025 number at 0.09%, up 28.0% from a year prior.
  • Return on Equity was 0.08% for Q4 2025 at Exact Sciences, up from 0.4% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.06% in Q2 2024 to a low of 0.42% in Q1 2025.
  • A 5-year average of 0.21% and a median of 0.21% in 2022 define the central range for Return on Equity.
  • Biggest YoY gain for Return on Equity was 28bps in 2025; the steepest drop was -36bps in 2025.
  • Exact Sciences' Return on Equity stood at 0.17% in 2021, then dropped by -16bps to 0.2% in 2022, then surged by 68bps to 0.07% in 2023, then plummeted by -463bps to 0.37% in 2024, then soared by 77bps to 0.08% in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Return on Equity are 0.08% (Q4 2025), 0.4% (Q3 2025), and 0.41% (Q2 2025).